Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan-Mar;36(1):14-22.
doi: 10.1080/10550887.2016.1211784. Epub 2016 Jul 22.

Opioid analgesic and benzodiazepine prescribing among Medicaid-enrollees with opioid use disorders: The influence of provider communities

Bradley D Stein  1   2 , Joshua Mendelsohn  3 , Adam J Gordon  2   4 , Andrew W Dick  5 , Rachel M Burns  1 , Mark Sorbero  1 , Regina A Shih  6 , Rosalie Liccardo Pacula  3
Affiliations

Opioid analgesic and benzodiazepine prescribing among Medicaid-enrollees with opioid use disorders: The influence of provider communities

Bradley D Stein et al. J Addict Dis. 2017 Jan-Mar.

Abstract

Opioid analgesic and benzodiazepine use in individuals with opioid use disorders can increase the risk for medical consequences and relapse. Little is known about rates of use of these medications or prescribing patterns among communities of prescribers. The goal of this study was to examine rates of prescribing to Medicaid-enrollees in the calendar year after an opioid use disorder diagnosis, and to examine individual, county, and provider community factors associated with such prescribing. 2008 Medicaid claims data were used from 12 states to identify enrollees diagnosed with opioid use disorders, and 2009 claims data were used to identify rates of prescribing of each drug. Social network analysis was used to identify provider communities, and multivariate regression analyses was used to to identify patient, county, and provider community level factors associated with prescribing these drugs. The authors also examined variation in rates of prescribing across provider communities. Among Medicaid-enrollees identified with an opioid use disorder, 45% filled a prescription for an opioid analgesic, 37% filled a prescription for a benzodiazepine, and 21% filled a prescription for both in the year following their diagnosis. Females, older individuals, individuals with pain syndromes, and individuals residing in counties with higher rates of poverty were more likely to fill prescriptions. Prescribing rates varied substantially across provider communities, with rates in the highest quartile of prescribing communities over 2.5 times the rates in the lowest prescribing communities. Prescribing opioid analgesics and benzodiazepines to individuals diagnosed with opioid use disorders may increase risk of relapse and overdose. Interventions should be considered that target provider communities with the highest rates of prescribing and individuals at the highest risk.

Keywords: Medicaid; Opioid use disorders; benzodiazepines; opioids; prescribing behavior; social network analysis.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Statement: Dr. Stein was previously an employee of Community Care Behavioral Health Organization, a non-profit managed behavioral health organization that managed behavioral health services of Medicaid-enrollees in Pennsylvania. Dr. Stein has also served on an Advisory Board for Otsuka Pharmaceuticals. Dr. Gordon receives royalties from Cambridge University Press and UptoDate for work unrelated to this topic. None of the other authors have any conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Illustration of how provider communities were identified using Medicaid claims
Figure 2
Figure 2
Percentage of patients receiving opioid analgesics, benzodiazepines, and both opioid analgesics and benzodiazepines by provider community quartile
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5th. Arlington, VA: American Psychiatric Publishing; 2013.
    1. Substance Abuse and Mental Health Services Administration. [Accessed March 8, 2016];The N-SSATS Report: Trends in the Use of Methadone and Buprenorphine at Substance Abuse Treatment Facilities: 2003 to 2011. 2013 http://archive.samhsa.gov/data/2k13/NSSATS107/sr107-NSSATS-Buprenorphine.... - PubMed
    1. Centers for Disease Control. Prescription Painkiller Overdoses in the US. Vitalsigns. 2011 Nov; 2011:Available at: http://www.cdc.gov/vitalsigns/pdf/2011-2011-vitalsigns.pdf.
    1. Manchikanti L, Fellows B, Ailinani H, Pampati V. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician. 2010 Sep-Oct;13(5):401–435. - PubMed
    1. Substance Abuse and Mental Health Services Administration. Drug Abuse Warning Network, 2011: National Estimates of Drug-Related Emergency Department Visits. HHS Publication No. (SMA) 13–4760, DAWN Series D-39. Rockville, MD: Substance Abuse and Mental Health Administration; 2013.

Publication types

LinkOut - more resources